Webinar: Introducing Agentic AI for Signal Management
Signals Agents transform signal management by delivering a connected, real time safety view.
Webinar: The Rise of Intelligence Agents
AI Intelligence agents that interpret regulatory change and assess real-time impact.
Bristol Myers Squibb’s (BMS) Patient Safety team embarked on an evolution journey, embracing advanced AI technologies and re-engineering core business processes.
Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.
Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.
In our checklist, we outline the most important criteria that leading organizations are keeping in mind when evaluating Agentic AI-powered regulatory intelligence solutions.
Discover how to take advantage of modular AI offerings that make it simple to track global regulatory changes and accelerate SPOR and ISO IDMP compliance.
Learn how ReporterX, powered by NavaX, serves as an intelligent front-end patient data collection application, enabling reporters across the globe to leverage AI-assisted capabilities.
In our checklist, we walk through the most important criteria to keep in mind when evaluating AI-driven data collection and reporting solutions.
Intensifying regulatory demands and rapidly growing analytical complexity ...
In our checklist, we outline the most important criteria that leading firms are keeping in mind to get the most out of AI and automation.
Watch ArisGlobal’s webinar to discover how organizations like yours are reimagining what’s possible with modern, AI-powered LifeSphere PV solutions designed specifically to empower pharma teams and future-proof their operations.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved